Oxidative stress, toxic hepatitis, and antioxidants with particular emphasis on zinc

Experimental and Molecular Pathology

Volumn 75, Issue 3, 2003, Pages 265-276

  Stehbens, William E ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

Acute hepatitis; Antioxidants; Cirrhosis; Nutritional requirements; Oxidative stress; Redox balance; Vitamins; Xenobiotics; Zinc

Indexed keywords

ALCOHOL; ALPHA TOCOPHEROL; ANTIOXIDANT; CARBOHYDRATE; CARBON TETRACHLORIDE; CYSTEINE PROTEINASE; EBSELEN; FREE RADICAL; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HALOTHANE; LIPID; MERCAPTAMINE; METHIONINE; MYCOTOXIN; NUCLEIC ACID; PARACETAMOL; POISON; PROTEIN; REACTIVE OXYGEN METABOLITE; SELENIUM; SPORIDESMIN; TOXIN; UBIQUINONE; UNINDEXED DRUG; XENOBIOTIC AGENT; ZEARALENONE; ZINC; ZINC CHLORIDE; ZINC SULFATE;

ACUTE DISEASE; CHRONIC DISEASE; DETOXIFICATION; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG METABOLISM; ENZYME METABOLISM; EXPERIMENT; EXPOSURE; HEPATITIS; HUMAN; LIVER CELL; LIVER CIRRHOSIS; LIVER METABOLISM; LIVER NECROSIS; LIVER TOXICITY; NONHUMAN; NUTRITIONAL REQUIREMENT; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PROPHYLAXIS; PROTEIN ANALYSIS; RECURRENT DISEASE; REVIEW; TOXIC HEPATITIS;

EID: 0242426419     PISSN: 00144800     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4800(03)00097-2     Document Type: Article

References (118)

1. Allen J.G., Masters H.G. Prevention of ovine lupinosis by the oral administration of zinc sulphate and the effect of such therapy on liver and pancreas zinc and liver copper. Aust. Vet. J. 56:1980;168-171.
2. Andersson C.-M., Hallberg A., Högberg T. Advances in the development of pharmaceutical antioxidants. Adv. Drug Res. 28:1996;65-180.
3. Becking G.C., Morrison A.B. Hepatic drug metabolism in zinc-deficient rats. Biochem. Pharmacol. 19:1970;895-902.
4. Beisel W.R. Zinc metabolism in infection. Brewer G.J., Prasad A.S. Current Aspects in Health and Disease. 1977;155-176 Alan R. Liss, New York.
5. Bhutta Z.A., Black R.E., Brown K.H., Gardner J.M., Gore S., Hidayat A., Khatun F., Martorell R., Ninh N.X., Penny M.E., Rosado J.L., Roy S.K., Ruel M., Sazawal S., Shanker A. Prevention of diarrhoea and pneumonia by zinc supplementation in children in developing countries pooled analysis of randomized controlled trials . J. Pediat. 135:1999;689-697.
6. 10 the Baycol case - a modern Pandora's box . Biomed. Pharmacother. 56:2002;56-59.
7. Burk R.F., Lawrence R.A., Lane J.M. Liver necrosis and lipid peroxidation in the rat as a result of paraquat and diquat administration. J. Clin. Invest. 65:1980;1024-1031.
8. Chvapil M. New aspects in the biological role of zinc a stabilizer of macromolecules and biological membranes . Life Sci. 13:1973;1041-1049.
9. Chvapil M. Effect of zinc on cells and membranes. Med. Clin. Nth. Am. 60:1976;799-812.
10. Chvapil M., Ryan J.N., Elias S.L., Peng Y.M. Protective effect of zinc on carbon tetrachloride-induced liver injury in rats. Exp. Mol. Pathol. 19:1973;186-196.
11. Crane F.L., Navas P. The diversity of coenzyme Q function. Mol. Aspects Med. 18:(Suppl):1997;S1-S6.
12. Dalton T.P., Shertzer H.G., Puga A. Regulation of gene expression by reactive oxygen. Annu. Rev. Pharmacol. Toxicol. 39:1999;67-101.
13. Dean R.T. Protein degradation in cell cultures general considerations on mechanisms and regulation . Fed. Proc. 39:1980;15-19.
14. Dean R.T., Gieseg S., Davies M.J. Reactive species and their accumulation on radical-damaged proteins. Trends. Biol. Sci. 18:1993;437-441.
15. de Vries H.R., Maxwell S.M., Hendrickse R.G. Aflatoxin excrement in children with kwashiorkor or marasmic kwashiorkor - a clinical investigation. Mycopathologia. 110:1990;1-9.
16. Dhawan D., Goel A. Further evidence for zinc as a hepatoprotective agent in rat liver toxicity. Exp. Mol. Pathol. 63:1995;110-117.
17. Diehl A.M. Alcoholic liver disease. Med. Clin. Nth. Am. 73:1989;815-830.
18. Di Luzio N.R., Hartman A.D. Role of lipid peroxidation in the pathogenesis of the ethanol-induced fatty liver. Fed Proc. 26:1967;1436-1442.
19. Dinsdale D., Williams R.B. The enhancement by dietary zinc deficiency of the susceptibility of the rat duodenum to colchicine. Br. J. Nutr. 37:1977;135-143.
20. Dreosti, I.B., 1997. Zinc: Nutritional aspects, in: Langley, A., Mangas, M. (Eds.), Zinc. National Environmental Health Forum, Monograph No. 2, pp. 10-15.
21. Durak I., Güven T., Birey M., Öztürk H.S., Kurtipek Ö., Yel M., Dikmen B., Canbolat O., Kavatcu M., Kaçmaz M. Halothane hepatotoxicity and hepatic free radical metabolism in guinea pigs the effects of vitamin E . Can. J. Anaesth. 43:1996;741-748.
22. Elias S., Chavpil M. Zinc and wound healing in normal and chronically ill rats. J. Surg. Res. 15:1973;63-69.
23. Ellis R.P., Vorhies M.W. Effect of supplemental dietary vitamin E on the serologic response of swine to an Escherichia coli bacterin. J. Am. Vet. Med. Assoc. 168:1976;231-232.
24. Ernster L., Dallner G. Biochemical, physiological and medical aspects of ubiquinone function. Biochim. Biophys. Acta. 1271:1995;195-204.
25. Farber J.L., Kyle M.E., Coleman J.B. Biology of disease. Mechanisms of cell injury by activated oxygen species. Lab. Invest. 62:1990;670-679.
26. Farrell G.C. Liver disease caused by drugs, anesthetics and toxins. Feldman M., Friedman L.S., Sleisinger M.H. Gastrointestinal and Liver Disease. seventh ed. 2002;1403-1447 Saunders, Philadelphia.
27. Frei B., Kim M.C., Ames B.N. Ubiquinol-10 is an effective lipid-soluble antioxidant at physiological concentrations. Proc. Natl. Acad. Sci. USA. 87:1990;4879-4883.
28. Gallagher C.H. The effect of antioxidants on poisoning by carbon tetrachloride. Aust. J. Exp. Biol. 40:1962;241-254.
29. Ghoshal A.K. New insights into the biochemical pathology of liver in choline deficiency. Crit. Rev. Biochem. Mol. Biol. 30:1995;263-273.
30. Glende E.A., Recknagel R.O. Biochemical basis for the in vitro pro-oxidant action of carbon tetrachloride. Exp. Mol. Pathol. 11:1969;172-185.
31. Goel A., Chauhan D.P., Dhawan D.K. Protective effects of zinc in chlorpyrifos induced hepatotoxicity a biochemical and trace element study . Biol. Trace Elem. Res. 74:2000;171-183.
32. Goel A., Dhawan D.K. Zinc supplementation prevents liver injury in chlorpyrifos-treated rats. Biol. Trace Elem. Res. 82:2001;185-200.
33. Golden M.H.N., Ramdath D. Free radicals in the pathogenesis of kwashiorkor. Proc. Nutr. Soc. 46:1987;53-68.
34. Goode H.F., Webster N.R. Antioxidants in intensive care medicine. Clin. Intensive Care. 4:1993;265-269.
35. Hall P., de la M. Pathology of alcoholic liver disease. MacSween R.N.M., Burt A.D., Portmann B.C., Ishak K.G., Scheuer P.J., Anthony P.P. Pathology of the Liver. fourth ed. 2002;273-311 Churchill Livingstone, London.
36. Halliwell B. Free radicals, antioxidants, and human disease curiosity, cause or consequence . Lancet. 344:1994;721-724.
37. Halliwell B. Antioxidants and human disease a general introduction . Nutr. Rev. 55:(11):1997;S44-S52.
38. Halliwell B., Gutteridge J.M.C. Free Radicals in Biology and Medicine. third ed. 1999;Oxford University Press, Oxford.
39. Harman A.W., Adamson G.M., Shaw S.G. Protection from oxidative damage in mouse liver cells. Toxicol. Lett. 64:1992;581-587.
40. Hayashi Y., Lalich J.J. Protective effect of mercaptoethylamine and cysteine against monocrotaline intoxication in rats. Toxicol. Appl. Pharmacol. 12:1968;36-43.
41. Heinzerling R.H., Nockels C.F., Quarles C.L., Tengerdy R.P. Protection of chicks against E. coli infection by dietary supplementation with vitamin E. Proc. Soc. Exper. Biol. Med. 146:1974;279-283.
42. Hendrickse R.G. Of sick turkeys, kwashiorkor, malaria, perinatal mortality, heroin addicts and food poisoning research on the influence of aflatoxins on child health in the tropics . Ann. Trop. Med. Parasitol. 91:1997;787-793.
43. 2 generation in liver mitochondria. Carcinogenesis. 21:2000;983-989.
44. Hughes, R.D., Wendon, J., Gimson, A.E.S., 1991. Acute liver failure. Gut (Suppl), S86-S91.
45. Ishak K.G. Hepatic histopathology. Schiff L., Schiff E.R. Diseases of the Liver. seventh ed. 1993;145-188 Lippincott, Philadelphia.
46. Ivanetich K.M., Thumser A.E.A., Ziman M.R., Kirsch R.E. Liver injury and regeneration. Liver Ann. 6:1987;91-162.
47. Jacob R.A., Burri B.J. Oxidative damage and defence. Am. J. Clin. Nutr. 63:1996;985S-990S.
48. Jollow D.J., Mitchell J.R., Potter W.Z., Davis D.C., Gillette J.R., Brodie B.B. Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Therap. 187:1973;195-202.
49. Kahn A.M., Ozeran R.S. Liver and serum zinc abnormalities in rats with cirrhosis. Gastroenterology. 53:1967;193-197.
50. Kaplowitz N., Tsukamoto K. Oxidative stress and liver disease. Prog. Liver Dis. 14:1996;131-159.
51. Kinsella J.E. Increased lipoperoxide content of orotic acid-induced fatty liver. Biochim. Biophys. Acta. 137:1967;205-207.
52. Kishi T., Takahashi T., Okamoto T. Cystolic NADPH-UQ reductase-linked recycling of cellular ubiquinol its protective effect against carbon tetrachloride hepatotoxicity in rat . Molec. Aspects Med. 18:1997;S71-S77.
53. Lenhartz H., Ndasi R., Anninos A., Bötticher D., Mayatepeck E., Telanye E., Leichsenring M. The clinical manifestations of the kwashiorkor syndrome is related to increased lipid peroxidation. J. Pediatr. 132:1998;879-881.
54. Lewis J.H., Zimmerman H.J. Drug-induced liver disease. Med. Clin. North Am. 73:1989;775-792.
55. Lieber C.S. Pathogenesis and early diagnosis of alcoholic liver injury. N. Engl. J. Med. 298:1978;888-893.
56. Lieber C.S. Mechanism of ethanol induced hepatic injury. Pharmacol. Ther. 46:1990;1-41.
57. Lieber C.S. Metabolism of ethanol and associated hepatotoxicity. Drug Alcohol Rev. 10:1991;175-202.
58. Liu B., Andrieu-Abadie N., Levade T., Zhang P., Obeid L.M., Hannun Y.A. Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-induced cell death. J. Biol. Chem. 18:1998;11313-11320.
59. Ludwig J.C., Chvapil M. Mechanisms of action of metal ions in hepatocytes. Sorenson J.R.J. Inflammatory Disease and Copper. 1982;565-580 Humana Press, NJ.
60. Maher J.J. Alcoholic liver disease. Feldman M., Friedman L.S., Sleisinger M.H. Gastrointestinal and Liver Disease Pathophysiology/Diagnosis/ Management . seventh ed., Vol. 2:2002;1375-1391 Saunders, Philadelphia.
61. Manary M.J., Leeuwenburgh C., Heinecke J.W. Increased oxidative stress in kwashiorkor. J. Pediat. 137:2000;421-424.
62. McClain C.J., Marsano L., Burk R.F., Bacon B. Trace metals in liver disease. Semin. Liver Dis. 11:1991;321-339.
63. McLean A.E.M., McLean E.K. The effect of diet and 1,1,1-trichloro-2,2- bis-(p-chlorophenyl) ethane (DDT) on microsomal hydroxylating enzymes and on sensitivity of rats to carbon tetrachloride poisoning. Biochem. J. 100:1966;564-571.
64. Mills P.R., Fell G.S., Bessent R.G., Nelson L.M., Russell R.I. A study of zinc metabolism in alcoholic cirrhosis. Clin. Sci. 64:1983;527-535.
65. Miranda C.L., Henderson M.C., Reed R.L., Schmitz J.A., Butcher D.R. Protective action of zinc against pyrrolizidine alkaloid-induced hepatotoxicity in rats. J. Toxicol. Environ. Health. 9:1982;359-366.
66. Mitchell J.R., Hinson J.A., Nelson S.D. Glutathione and drug-induced tissue lesions. Arias I.M., Jakoby W.B. Glutathione Metabolism and Function . 1976;357-367 Raven Press, New York.
67. Mitchell J.R., Jollow D.J. Metabolic activation of drugs to toxic substances. Gastroenterology. 68:1975;392-410.
68. Mortimer P.H. The experimental intoxication of sheep with sporidesmin, a metabolic product of Pithomyces chartarum. IV. Histological and histochemical examinations of orally-dosed sheep. Res. Vet. Sci. 4:1963;166-185.
69. Munday R. Studies in the mechanism of toxicity of the mycotoxin sporidesmin. 2. Evidence for intracellular generation of superoxide radical from sporidesmin. J. Appl. Toxicol. 4:1984;176-181.
70. Munday R., Manns E., Mortimer P.H. Effect of antioxidants on the toxicity of the facial eczema toxin, sporidesmin in sheep. Proc. N.Z. Soc. Animal Prod. 43:1983;209-212.
71. Nakae D. Endogenous liver carcinogenesis in the rat. Pathol. Internat. 49:1999;1028-1042.
72. Niki E. Mechanisms and dynamics of antioxidant action of ubiquinol. Mol. Aspects Med. 18:1997;S63-S70.
73. Nordmann R. Alcohol and antioxidant systems. Alcohol & Alcoholism. 28:1994;513-522.
74. Parkinson A. Biotransformation of xenobiotics. Klaassen C.D. Casarett and Doull's Toxicology. sixth ed. 2001;133-224 McGraw-Hill, New York.
75. Peraica M., Radić B., Lucić A., Pavlović M. Toxic effects of mycotoxins in humans. Bull. World Health Org. 77:1999;754-766.
76. Pessayre D., Berson A., Fromenty B., Mansouri A. Mitochondria in steatohepatitis. Sem. Liver Dis. 21:2001;57-69.
77. Pessayre D., Mansouri A., Fromenty B. Nonalcoholic steatosis and steatohepatitis V. Mitochondrial dysfunction in steatohepatitis. Am. J. Physiol. 282:2002;G193-G199.
78. Petering H.G. Some observations on the interaction of zinc, copper, and iron metabolism in lead and cadmium toxicity. Environ. Health Perspect. 25:1978;141-145.
79. Pitt J.I. Toxigenic fungi and mycostatins. Br. Med. Bull. 56:2000;184-192.
80. Platz, E.A., Helzisouer., 2001. Selenium, zinc, and prostate cancer. Epidemiol. Rev. 23, 93-101.
81. Prasad A.S. The role of zinc in gastrointestinal and liver disease. Clin. Gastroenterol. 12:1983;713-741.
82. Prasad A.S. Zinc an overview . Nutrition. 11:1995;93-99.
83. Prescott L.F., Critchley J.A.J.H. The treatment of acetaminophen poisoning. Ann. Rev. Pharmacol. Toxicol. 23:1983;87-101.
84. Recknagel R.O. Carbon tetrachloride hepatotoxicity. Pharmacol. Rev. 19:1967;145-208.
85. Recknagel, R.O., Glende, E.A., 1973. Carbon tetrachloride: an example of lethal cleavage. C.R.C. Crit. Rev. Toxicol. Nov., 263-297.
86. Record I.R., Jannes M., Dreosti I.E. Protection by zinc against UVA- and UVB-induced cellular and genomic damage in vivo and in vitro. Biol. Trace Element Res. 53:1996;19-25.
87. Reid G.M. The pharmacological role of zinc evidence from clinical studies of animals . Med. Hypotheses. 7:1981;207-215.
88. Ritland S., Aaseth J. Trace elements and the liver. J. Hepatol. 5:1987;118-122.
89. Rubin E., Lieber C.S. Experimental alcoholic hepatic injury in man ultrastructural changes . Fed. Proc. 26:1967;1458-1467.
90. Sandstead, H.H., Penland, J.G., Alcock, N.W., 1997. Essentiality of zinc in human nutrition, in: Langley, A., Mangas, M. (Eds.), Zinc, National Environmental Health Forum Monograph Metal Series No. 2, pp. 1-9.
91. Schiødt F.V., Rochling F.A., Casey D.L., Lee W.M. Acetaminophen toxicity in an urban country hospital. N. Engl. J. Med. 337:1997;1112-1117.
92. Seeff L.B., Cuccherini B.A., Zimmerman H.J., Adler E., Benjamin S.B. Acetaminophen hepatotoxicity in alcoholics. Ann. Int. Med. 104:1986;399-404.
93. Sen C.K., Roy S., Packer L. Oxidants and antioxidants in glutamate-induced cytotoxicity. Packer L., Ong A.S.H. Biological Oxidants and Antioxidants. 1998;5-13 AOCS Press, Champaign.
94. Shigesawa T., Sato C., Marumo F. Significance of plasma glutathione determination in patients with alcoholic and non-alcoholic liver disease. J. Gerontol. Hepatol. 7:1992;7-11.
95. Snyder S.L., Walker R.I. Inhibition of lethality in endotoxin-challenged mice treated with zinc chloride. Infect. Immun. 13:1976;998-1000.
96. Spallholz J.E., Martin J.L., Gerlach M.L., Heinzerling R.H. Immunologic responses of mice fed diets supplemented with selenite selenium. Proc. Soc. Exp. Biol. Med. 143:1975;685-689.
97. Tamburro C.H. Chemical hepatitis pathogenesis, detection and management . Med. Clin. North Am. 63:1979;545-566.
98. Takahashi T., Sugimoto N., Takahata K., Okamoto T., Kishi T. Cellular antioxidant defence by a ubiquinol-regenerating system coupled with cytosolic NADPH-dependent ubiquinone reductase protective effect against carbon tetrachloride-induced hepatotoxicity in the rat . Biol. Pharm. Bull. 19:1996;1005-1012.
99. Tapell A.L. Lipid peroxidation damage to cell components. Fed. Proc. 32:1973;1870-1874.
100. Taylor A. Toxicity of sporidesmins. Ajl S.J. Fungal Toxins. Vol. 8:1972;368-371 Academic Press, New York.
101. Tengerdy R.P., Mathias M.M., Nockels C.F. Vitamin E, immunity and disease resistance. Adv. Exp. Med. Biol. 135:1980;27-42.
102. Tengerdy R.P., Nockels C.F. Vitamin E and vitamin A protects chickens against E. coli infection. Poult. Sci. 54:1975;1292-1296.
103. Towers N.R., Smith B.L. The protective effect of zinc sulphate in experimental sporidesmin intoxication of lactating dairy cows. N.Z. Vet. J. 26:1978;199-202.
104. Truong-Tran A.Q., Ho L.H., Chai F., Zalewski P.D. Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. J. Nutr. 130:2000;1459S-1466S.
105. Tsuchiya M., Kagan V.E., Freisleben H.-J., Manabe M., Packer L. Antioxidant activity of alpha-tocopherol, beta-carotene, and ubiquinol in membranes cis-parinaric acid-incorporated liposomes . Methods Enzymol. 234:1994;371-383.
106. Turano P., Turner W.J. Thin-layer chromatography of chlorpromazine metabolism. J. Chromatogr. 75:1973;277-293.
107. Vallee B.L., Fulchuk K.H. The biochemical basis of zinc physiology. Physiol. Rev. 73:1993;79-118.
108. Vallee B.L., Wacker W.E.C., Bartholomay A.F., Hoch F.L. Zinc metabolism in hepatic dysfunction. II. Correlation of metabolic patterns with biochemical findings. N. Engl. J. Med. 257:1957;1055-1065.
109. Vessey D.A. Metabolism of zenobiotics by the human liver. Zakim D., Boyer T.D. Hepatology A Textbook of Liver Disease, Vol. 1 . third ed. 1996;257-305 Saunders, Philadelphia.
110. 5 reductase on the antioxidant function of coenzyme Q in the plasma membrane. Mol. Aspects Med. 18:1997;S7-S13.
111. Wacker W.E.C., Ulmer D.D., Vallee B.L. Metalloenzymes and myocardial infarction. II. Malic and lactic acid dehydrogenase activities and zinc concentration in serum. N. Engl. J. Med. 255:1956;449-456.
112. Weismann K., Roed-Petersen J., Hjorth N., Kapp H. Chronic zinc deficiency syndrome in a beer drinker with a Billroth II reaction. Int. J. Dermatol. 15:1976;757-761.
113. Williams A.T., Burk R.F. Carbon tetrachloride hepatotoxicity an example of free radical-mediated injury . Semin. Liver Dis. 10:1990;279-284.
114. Yang G., Chen J., Wen Z., Ge K., Zhu L., Chen X., Chen X. The role of selenium in Keshan disease. Adv. Nutr. Res. 6:1984;203-231.
115. Younes M., Heger B., Wilhelm K.-P., Siegers C.-P. Enhanced in vivo-lipid peroxidation associated with halothane tepatotoxicity in rats. Pharmacol. Toxicol. 63:1988;52-56.
116. Zimmerman H.J. Drug-induced liver disease. Schiff E.R., Sorrell M.F., Maddrey W.C. Schiff's Diseases of the Liver. eighth ed. 1999;973-1064 Lippincott-Raven, Philadelphia.
117. Zimmerman H.J., Ishak K.G. Hepatic injury due to drugs and toxins. MacSween R.N.M., Anthony P.P., Scheuer P.J., Burt A.D., Portman B.C. Pathology of the Liver. third ed. 1994;563-633 Churchill Livingstone, London.
118. Zimmerman H.J., Maddrey W.C. Toxic and drug induced hepatitis. Schiff L., Schiff E.R. Diseases of the Liver, Vol. 1. seventh ed. 1993;707-783 J.B. Lippincott, Philadelphia.